BIOLEXIS THERAPEUTICS
Biolexis Therapeutics is a cutting-edge FIELDS technology to design potent and selective small molecule therapeutics. The company was founded in 2021 by Dr. Hari Vankayalapati and Dr. David J. Bearss and is headquartered in Sandy, Utah, United States.
BIOLEXIS THERAPEUTICS
Social Links:
Industry:
Health Care Pharmaceutical Therapeutics
Founded:
2021-01-01
Address:
Sandy, Utah, United States
Country:
United States
Website Url:
http://www.biolexistx.com
Total Employee:
1+
Status:
Active
Contact:
385-289-1282
Similar Organizations
Penrose TherapeuTx
Penrose TherapeuTx specializes in technological advancements for treating advanced cancers using small-molecule therapies.
Founder
Official Site Inspections
http://www.biolexistx.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Biolexis Therapeutics"
Biolexis Therapeutics, Inc. Information - RocketReach
Biolexis Therapeutics, Inc. is a Biotechnology Research company located in Lehi, Utah with 13 employees. Find top employees, contact details and business statistics at RocketReach.See details»
Biolexis Therapeutics Company Profile | Management and
Biolexis Therapeutics Profile and History Founded in 2021 and headquartered in American Fork, Utah, Biolexis Therapeutics is a privately held clinical-stage biopharmaceutical company …See details»
Biolexis Therapeutics Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Biolexis Therapeutics Inc. of Lehi, UT. Get the latest business insights from Dun & Bradstreet.See details»
Biolexis Therapeutics - Crunchbase Company Profile & Funding
Biolexis Therapeutics is a privately held biopharmaceutical company committed to developing novel targeted therapeutics.See details»
Biolexis Company Profile - Craft
Biolexis has 5 employees at their 1 location and $10 m in total funding,. See insights on Biolexis including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
About – Biolexis
Mission Statement. Our mission is to pioneer innovative drug therapies that transform the landscape of healthcare for individuals battling chronic diseases rooted in metabolic disorders. …See details»
Biolexis Therapeutics, Inc. - Golden
Company attributes Industry Artificial Intelligence (AI) Biotechnology Location Sandy, Utah Full Address 9980 SOUTH, 300 WEST, SUITE #200 SANDY, UT 84070 CIK Number 1,914,060 …See details»
Overview, News & Similar companies - ZoomInfo.com
Mar 31, 2024 View Biolexis Therapeutics (www.biolexistx.com) location in Utah, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Biolexis Therapeutics 2025 Company Profile: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Biolexis Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Biolexis Therapeutics – Entrepreneur & Investor Life Sciences Summit
Biolexis Therapeutics Overview Biolexis Therapeutics is a biotech company with a modern, chemical-biological approach to accelerating drug discovery. We utilize our proprietary wet-lab …See details»
Biolexis Therapeutics, Inc. - LinkedIn
Biolexis Therapeutics, Inc. | 1,176 followers on LinkedIn. Accelerating Drug Discovery | Moleculernâ„¢ – The Next Evolution in Drug Discovery Screening each Moleculernâ„¢ fragment …See details»
Biolexis Therapeutics - Products, Competitors, Financials, …
Biolexis is committed to advancing the treatment of chronic metabolic disorders to enhance patients' lives worldwide. For more information about Biolexis Therapeutics and its pioneering …See details»
Biolexis
Biolexis is developing multiple oral small molecules that target GLP-1 in a unique manner while reducing the side effects of currently approved drugs and many in development. Also in our …See details»
Biolexis Therapeutics | VentureRadar
Biolexis is able to provide better clinical candidates faster and at less cost through our proprietary FIELDSâ„¢ platform. FIELDSâ„¢ is a combination of a proprietary fragment screening library that …See details»
Biolexis Therapeutics - VentureRadar
"Biolexis is able to provide better clinical candidates faster and at less cost through our proprietary FIELDSâ„¢ platform. FIELDSâ„¢ is a combination of a proprietary fragment screening library that …See details»
Biolexis Therapeutics - highergov.com
Biolexis Therapeutics (UEI JP7YJFC53PX4, CAGE 9BYJ9) based in American Fork UT federal contracts, grants, registrations, vehicles, partnerships, and analysisSee details»
Biolexis Therapeutics | Drug Discovery - BioUtah
Proprietary AI platform to discover and develop our own NCEs. Our pipeline projects are available for licensing or partnering. And drug development in oncology indications.See details»
Halia Therapeutics Announced Neuroinflammation Collaboration
Jul 31, 2024 Utilizing its proprietary MolecuLern â„¢ process, Biolexis accelerates the identification and development of novel therapeutic candidates, addressing various medical …See details»
Biolexis Therapeutics: Employee Directory | ZoomInfo.com
Dec 7, 2023 Biolexis Therapeutics Employee Directory Biolexis Therapeutics corporate office is located in 858 S Auto Mall Dr Ste 102, American Fork, Utah, 84003, United States and has 7 …See details»
Biolexis Therapeutics - workinbiotech.com
Biolexis Therapeutics specializes in AI-enabled drug discovery. Their proprietary MolecuLernâ„¢ platform accelerates the identification and development of novel therapeutic candidates for a …See details»